STOCK TITAN

Hims & Hers Health Inc Stock Price, News & Analysis

HIMS NYSE

Welcome to our dedicated page for Hims & Hers Health news (Ticker: HIMS), a resource for investors and traders seeking the latest updates and insights on Hims & Hers Health stock.

Hims & Hers Health Inc (HIMS) delivers innovative telehealth solutions through its direct-to-consumer platform, connecting users with licensed professionals for personalized care, wellness products, and prescription services. This news hub provides investors and industry observers with essential updates about the company’s operational milestones and market developments.

Access real-time announcements including quarterly earnings reports, strategic partnerships, product expansions, and regulatory filings. Our curated collection ensures you stay informed about HIMS’ position in the competitive digital healthcare sector without needing to track multiple sources.

Key updates across these areas:

Financial Performance: Earnings calls and SEC filings
Service Innovations: New telehealth offerings and treatment categories
Strategic Growth: Partnerships and market expansion initiatives
Regulatory Compliance: FDA updates and healthcare policy impacts

Bookmark this page for streamlined access to verified HIMS developments. Combine these updates with our analysis tools on Stock Titan to monitor the company’s evolving role in reshaping accessible healthcare solutions.

Rhea-AI Summary

Hims & Hers Health, Inc. (NYSE:HIMS) announced participation in the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021. CEO Andrew Dudum and Chief Medical Officer Patrick Carroll will hold one-on-one meetings and a live webcast of Dudum's fireside chat is scheduled for 4:20 PM ET. The webcast will be accessible on Hims & Hers investor relations website and archived for 90 days. The company, founded in November 2017, offers a multi-specialty telehealth platform providing access to healthcare for various conditions across the U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
conferences
-
Rhea-AI Summary

Hims & Hers (NYSE: HIMS) and Walgreens (NASDAQ: WBA) have announced a collaboration to enhance access to health and wellness solutions. Hims & Hers products, including supplements and sexual health offerings, will be available at over 7,000 Walgreens locations and on walgreens.com starting early November. This partnership aims to destigmatize health topics and support Hims & Hers' goal of mass market accessibility, providing trusted health products to consumers in the U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.97%
Tags
none
-
Rhea-AI Summary

Hims & Hers has launched the Climax Delay Wipes, a non-prescription treatment aimed at addressing premature ejaculation, which affects nearly 1 in 4 men. These single-use benzocaine wipes are designed to help men maintain erections and gain better control over their climax. This addition complements existing products like Climax Delay Spray and various prescription options available through telehealth consultations. CEO Andrew Dudum emphasized the company's mission to enhance personalized healthcare access, providing a range of solutions for sexual health.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.97%
Tags
none
Rhea-AI Summary

Hims & Hers Health, a telehealth platform, will release its fiscal third quarter financial results on November 10, 2021, after the market closes. A conference call is scheduled for 5:00 p.m. E.T. The company connects consumers to healthcare professionals for a variety of medical concerns, including primary care and mental health. Hims & Hers operates across all 50 states and Washington, D.C., providing accessible healthcare solutions. Investors and media are invited to access the live call or listen to a replay online.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.25%
Tags
-
Rhea-AI Summary

Regis Corporation (NYSE:RGS) announces John Davi as the new Chief Technology Officer, aiming to enhance its Opensalon ecosystem. With over 20 years in technology, Davi has previously worked with BriteCore and MINDBODY, and has experience in artificial intelligence and media solutions. His expertise is expected to drive technology development and improve franchisee support. Regis operates the world's largest franchise network of hair salons, with 5,917 locations globally as of June 30, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.78%
Tags
none
-
Rhea-AI Summary

Hims & Hers Health, Inc. (NYSE: HIMS) has partnered with The Vitamin Shoppe to expand the availability of its haircare products. Starting now, customers can purchase Hims & Hers products both online and in over 280 Vitamin Shoppe locations. This partnership will initially focus on haircare solutions, including popular items such as Minoxidil treatments and biotin gummies, with plans for future expansion into other product lines. The collaboration aims to enhance consumer access to personalized health and wellness solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.36%
Tags
partnership
Rhea-AI Summary

Hims & Hers Health has launched new skincare offerings, including the Hims Overnight Anti-Aging Duo and Hers Clear Skin System. The Overnight Anti-Aging Duo features a customizable prescription Anti-Aging Cream and a nonprescription Goodnight Wrinkle Cream targeted at wrinkles and sun damage. The Hers Clear Skin System offers a customizable prescription acne cream alongside hydrating cleanser and moisturizer. Both products emphasize individual customization through consultations with healthcare providers, enhancing the company's telehealth service model.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
none
-
Rhea-AI Summary

Hims & Hers Health has launched a new D-Mannose dietary supplement, aimed at improving urinary tract health for women. Available on ForHers.com, this product comes in single-serve packets that combine D-Mannose, vitamins, and electrolytes. The initiative addresses a significant health need, as 30-40% of women experiencing a urinary tract infection will have another within six months. This highlights the company's commitment to providing holistic health solutions that are accessible and user-friendly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.58%
Tags
none
-
Rhea-AI Summary

Hims & Hers announced a strategic partnership with REVOLVE, allowing a diverse range of health and wellness products to be sold on REVOLVE.com. This collaboration targets Millennial and Generation Z consumers by offering affordable skincare, hair care, sleep supplements, and sexual health products. Both companies aim to enhance their brands' appeal in the consumer health and fashion sectors. This partnership follows Hims & Hers' role as the exclusive wellness partner at REVOLVE's New York Fashion Week events, further solidifying their joint brand outreach.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.37%
Tags
none
Rhea-AI Summary

Hims & Hers Health, Inc. (NYSE:HIMS) announced participation in two significant conferences. The first is Citi's 2021 Virtual Global Technology Conference from September 13-15, with individual investor meetings on September 14. The second is the Raymond James Consumer Conference on September 14, featuring a live webcast with CEO Andrew Dudum at 4:20 PM ET. Hims & Hers, founded in November 2017, is a telehealth platform connecting consumers to healthcare professionals across the U.S., offering a range of health and wellness products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.86%
Tags
conferences

FAQ

What is the current stock price of Hims & Hers Health (HIMS)?

The current stock price of Hims & Hers Health (HIMS) is $49.47 as of May 6, 2025.

What is the market cap of Hims & Hers Health (HIMS)?

The market cap of Hims & Hers Health (HIMS) is approximately 6.4B.
Hims & Hers Health Inc

NYSE:HIMS

HIMS Rankings

HIMS Stock Data

6.37B
189.97M
11.25%
79.06%
23.34%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States
SAN FRANCISCO